Fundraising Fox
Tulavi Therapeutics
Mountain View, US · Founded 2018 · Delaware corporation · 50 employees on LinkedIn · 2 known investors
Find your way into Tulavi Therapeutics
Sign up to see every warm intro you have to Tulavi Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Tulavi Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Tulavi develops medical devices for peripheral nerve surgery, aiming to improve surgical treatment options and patient outcomes in nerve care. The company builds tools intended for surgical use to address gaps in current treatments.
Founders & leadership
Tulavi Therapeutics was founded in 2018 by Farhad Khosravi and Fred Khosravi.
FK
Farhad KhosraviCo-founder
JV
CB
Corinne BrightNamed on SEC filing
Board
Investors · 2
Reported raises · per SEC filings
Form D private placements$14.5M disclosed across 4 rounds · 2018–2021
▶$1MraisedDec 2021 · 9 investors · BiotechnologyRule 506(b)
▶$1MraisedDec 2021 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Corinne BrightExecutive Officer, Director
- Farhad KhosraviDirector
- Henry ChenDirector
- Amar SawhneyDirector
- Steve WillamsonDirector
- Tara ButlerDirector
- Greg CasciaroDirector
- Offering amount
- $1M
- Amount sold
- $1M
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$7.5MraisedMar 2021 · 3 investors · BiotechnologyRule 506(b)
▶$7.5MraisedMar 2021 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Farhad KhosraviDirector
- Henry ChenDirector
- Amar SawhneyDirector
- Steve WillamsonDirector
- Tara ButlerDirector
- Corinne BrightExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $7.5M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$3MraisedMay 2020 · 2 investors · BiotechnologyRule 506(b)
▶$3MraisedMay 2020 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Farhad KhosraviDirector
- Amar SawneyDirector
- Corinne BrightExecutive Officer, Director
- Henry ChenDirector
- Offering amount
- $5M
- Amount sold
- $3M
- First sale
- May 2020
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$3MraisedDec 2018 · 3 investors · Other Health CareRule 506(c)
▶$3MraisedDec 2018 · 3 investors · Other Health Care
Rule 506(c)Officers, directors & promoters on the filing
- Henry ChenDirector
- Corinne BrightExecutive Officer, Director
- Farhad KhosraviExecutive Officer, Director
- Offering amount
- $4M
- Amount sold
- $3M
- Minimum investment
- $160K
- First sale
- Apr 2018
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Globus MedicalGlobus Medical designs and manufactures spine, trauma, and robotic surgical products for the orthopedic medical device market. The company serves hospitals and surgical centers globally.
Noctrix HealthNoctrix Health develops clinically validated wearable therapeutics for managing chronic neurological disorders, with its first product Nidra receiving FDA De Novo authorization and dedicated CMS HCPCS codes. The company targets patients living with chronic conditions such as restless legs syndrome, offering prescription-grade therapy through medical devices.
PowerPower builds a patient-friendly platform to discover and enroll in clinical trials, serving patients seeking access to research studies and researchers seeking to improve patient recruitment. The company operates in the healthcare technology and clinical research industry.
Companies working in the same space as Tulavi Therapeutics.
In the news
Frequently asked questions
- What does Tulavi Therapeutics do?
- Tulavi develops medical devices for peripheral nerve surgery, aiming to improve surgical treatment options and patient outcomes in nerve care. The company builds tools intended for surgical use to address gaps in current treatments.
- Who founded Tulavi Therapeutics?
- Tulavi Therapeutics was founded by Farhad Khosravi, Fred Khosravi in 2018.
- Who are Tulavi Therapeutics's investors?
- Tulavi Therapeutics's investors include Ascension Ventures, Delos Capital.
- How much funding has Tulavi Therapeutics raised?
- Tulavi Therapeutics has disclosed $14.5M raised across 4 rounds.
- Where is Tulavi Therapeutics headquartered?
- Tulavi Therapeutics is headquartered in Mountain View, US.